



ANTIFUNGAL ACTIVITY OF ENDOPHYTIC FUNGI ISOLATED FROM LANNEA COROMANDELICA–
AN INSILICO APPROACH 
Original Article 
 
N. PREMJANUa*, C. JAYNTHYb, S. DIVIYAb 
aDepartment of Biochemistry, Dental College and Hospital, Sathyabama University, Chennai, bDepartment of Bioinformatics, Sathyabama 
University, Chennai 
Email: janu6kishore@gmail.com   
 Received: 24 Oct 2015 Revised and Accepted: 30 Mar 2016 
ABSTRACT  
Objective: The objective of this research was to isolate endophytic fungi from Lannea coromandelica having antifungal activity potential and to 
isolate the secondary metabolite from the dominant fungi and predict the probable mechanism behind its activity. 
Methods: The endophytic fungi were isolated from leaves of Lannea coromandelica by surface sterilization method. Then fungal biomass was 
extracted for intracellular metabolites by using ethyl acetate as solvent. The crude extract was filtered, and the filtrate was dried under vacuum at 
40 °C. The filtrate was analysed for antifungal activity. The fungi which showed the maximum activity was identified and the metabolite present in 
the ethyl acetate extract was characterized and identified by GC-MS (Gas-Chromatography Mass-spectrophotometry) analysis. Further, these 
compounds were docked against the target protein Lanosterol 14-alpha demethylase to unravel and predict the probable mechanism behind the 
antifungal activity of secondary metabolite. 
Results: Aspergillus flavus, Aspergillus niger, Alternaria alternata and Colletotrichum gloeosporioides were isolated and identified based on their 
morphological features as endophytic fungi. Among the four dominant fungi, the antifungal activity of Aspergillus flavus showed the maximum 
activity with an inhibitory zone of 26.22 mm against Candida albicans and 16.72 mm against Malassezia pachydermis. Further, the secondary 
metabolite was identified by GC-MS (Gas-Chromatography Mass-spectrophotometry) () analysis and found to be Kojic Acid, Octadecanoic acid, n-
Hexadecanoic Acid, diethyl Phthlate, 3-Phenyl Propionic Acid. These compounds were docked with the target protein and were able to bind at an 
active site similar to that of Flucanozole a known inhibitor. 
Conclusion: The finding of this work clearly indicates that the metabolite produced by the endophytic fungus could be used as an alternative source 
of antifungal agents against clinical pathogens. 
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INTRODUCTION 
In the last 15 y, there has been an alarming increase in life-
threatening systemic fungal infections of varying types which are 
observed in immunosuppressed/immunocompromised person such 
as AIDS, cancer, and transplant patients. Candida sp. have emerged 
as significant pathogens in recent decades as a consequence of 
increasing numbers and population of immunocompromised 
patients [1]. As a result, they have become a major direct cause of 
death in patients being treated for malignant diseases and emerging 
immune deficiency diseases [2]. Management of fungal infections 
have become more complex due to lack of a number of effective 
antifungal drugs, problems of drug safety, side effects, resistance and 
effectiveness of drug forms [3]. Therefore, there is an urgent need to 
improve currently used drugs, to design new drugs and to explore an 
alternate source of novel drugs through various mechanisms, for 
better treatment 
Endophytic fungi are a group of microorganism colonized in inter 
and intracellular host plants without causing any disease, plays 
important physiological roles and ecological roles [4]. After 
colonization many fungal endophytes may occupy a large area 
relatively and create an obstacle for other endophytic species by 
competing [5] or by producing antagonistic metabolites [6, 7]. After 
the discoveries of endophytes which reside in unique biological 
niche that is intracellular cells of the plants, created a worldwide 
curiosity among scientist which led to isolation of endophytes and to 
study their natural products. It has been observed that plants 
harbour a myriad of endophytes, possessing enormous metabolic 
diversity and diverse bioactive compounds that can be used as a 
therapeutic agent against emerging human diseases such as cancer 
and infectious diseases [8, 9]. It has been reported that mainly the 
filamentous fungi, are capable of producing a large number of 
chemically different secondary metabolites [10], which possess 
diversified functions and can be used as antimicrobials, antifungal 
and antivirals. These metabolites have high chemical diversity which 
comprises of alkaloids, terpenoids, quinones, peptides, xanthones 
and phenols [4]. Due to the presence of the above-mentioned 
properties, it may provide numerous lead compounds for the 
development of new drugs, directly, or as an inspiration for 
synthetic drugs [8]. A considerable body of research has investigated 
the diversity, ecological role, secondary metabolites and bioactivity 
of the endophytic fungi isolated from various medicinal plants [11]. 
One such plant studied is Lannea coromandelica, which is commonly 
known as “The Indian Ash Tree” belonging to the Anacardiaceae 
family. The bark and leaves of this tree have been used to treat 
various aliment by villagers and tribal people. Lannea coromandelica 
is considered to have antimicrobial, antifungal and antiviral 
properties [12]. Apart from this, it is claimed to have anti-
inflammatory, zoosporicidal, tissue healing, and tissue regeneration 
capacity. It is also used in the treatment of skin diseases, injuries, 
diarrhoea, particularly in young children, ulcers, impotence, vaginal 
troubles, heart diseases, gout, rheumatism, sore eyes, dysentery, and 
as an antidote in coma caused by the narcotics [13-15]. 
In this study an attempt was made to investigate and identify the 
antifungal metabolite produced by the fungal endophytes by GC-MS 
(Gas-Chromatography Mass-Spectrophotometry) analysis. Further 
studies were carried out to evaluate the interactions of metabolites 
present in the ethyl acetate extract of Aspergillus flavus by using In 
silico docking method for antifungal analysis with Lanosterol 14-
alpha demethylase as target protein. Our study dealt with the 
assessment of the interactions between ligands and target protein 
by molecular docking method in order to calculate the minimum 
binding energy (kcal/mol) between them. 
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MATERIALS AND METHODS 
Isolation and extraction of metabolite 
The endophytic fungi were isolated from healthy leaves of Lannea 
coromandelica by using potato dextrose agar medium and stored at 
4 °C. They were identified as Aspergillus  flavus Aspergillus niger, 
Alternaria alternata, and  Collectotrichum gloeosporioides based on 
morphological features [16]. The strains of were inoculated in a 
production media and incubated at 28 °C for 12 d, and biomass was 
then harvested. The fungal biomass was extracted for intracellular 
metabolites by using ethyl acetate as solvent, and this extraction was 
repeated three times. The crude extract was filtered through 
whatman No 1 filter paper, and the filtrate was dried under vacuum 
at 40 °C. The filtrate was analysed for antifungal activity. Further 
secondary metabolites of Aspergillus flavus were identified by using 
GC-MS analysis, by matching with known compound library. 
Antifungal activity (Agar-well diffusion method)  
For antifungal assay (SA) Sabouraud’s agar medium (Himedia, 
Mumbai) was prepared freshly and sterilized, then a pinch amount 
of streptomycin was added and mixed well. Then 20 ml of the media 
was poured into each petri plate and allowed to solidify. The test 
fungal cultures (3×105cfu/ml) namely Candida albicans and 
Malassezia pachydermis were evenly spread over the (SA) 
Sabouraud’s agar medium (Himedia, Mumbai) surface by using 
sterile cotton swab. Then a well 0.5 cm was made in the medium by 
using sterile cork borer, 150μg/ml of the ethyl acetate extracts of 
endophytic fungi was transferred into separate wells. Then these 
plates were incubated at 27o C for 48-72 h. Fluconazole was used as 
a control. After incubation period the results were observed and 
measured, the diameter of inhibition zone around the each well.  
In silico–methodology 
The isolated endophyte produced several compounds as secondary 
metabolite which had bioactivity. The compounds identified by GC-
MS analysis was screened against the target protein. The target 
protein Lanosterol 14-alpha demethylase (PDB ID: 3LD6) were 
retrieved from the (PDB) protein data bank (http://www. rcsb. 
org/pdb/). The compound details were retrieved from the Pub chem 
database, and the chemical structure was generated from SMILES 
notation by using the Chemsketch software (http://www. acdlabs. com). 
Docking studies carried out in Ligand Fit (Discovery Studio 2.0) [17]. It is 
based on a cavity detection algorithm and Monte Carlo conformational 
search algorithm for generating ligand poses consistent with the active 
site shape; hydrogen bonds were added and CHARMm force field was 
applied to all molecules. After applying CHARMm force field macro 
molecule 3LD6 was assigned as receptor. The receptor cavity was 
searched using flood filling algorithm and partition site was adjusted for 
the better fitments of molecule in the partition site of receptor. The 
comparative docking studies of the metabolites obtained from the result 
of GC MS for all molecules were performed. The determination of the 
ligand binding affinity was calculated using Dock score. They were used 
to estimate the ligand-binding energies. 
RESULTS AND DISCUSSION 
The endophytic fungi, namely Aspergillus flavus, Aspergillus niger, 
Colletotrichum gloeosporioides, and Alternaria alternata were 
isolated from Lannea coromandelica. Since ethyl acetate is the best 
solvent for extracting antifungal compounds [18]. The ethyl acetate 
extract of endophytic fungi were further taken for testing their 
activity against the test dermatophytic fungi namely Candida 
albicans and Malassezia pachydermis. 
Antifungal activity of Aspergillus flavus shows the maximum 
inhibitory zone of 26.22 mm against Candida albicans and 16.72 mm 
against Malassezia pachydermis (table 1). Whereas Aspergillus niger 
didn’t show significant inhibition against the test pathogens and the 
inhibition zone ranges from 8.95 mm to 12.56 mm respectively. 
Alternaria alternata did not have any significant inhibition against 
Candida albicans with a zone of inhibition of 9.57 mm but shows 
moderate inhibition against Malassezia pachydermis with an 
inhibitory zone of 15.11 mm. On the contrary, Colletotrichum 
gloeosporioides showed a significant inhibition zone of 21.13 mm 
activity against Candida albicans but did not show any significant 
inhibition towards Malassezia pachydermis with a zone of 12.5 mm.
 
Table 1: Antifungal activity of endophytic fungi against fungal pathogen 
Endophyte Candida albicans Malassezia pachydermis 
Aspergillus flavus 26.22±0.20 16.72±0.21 
Aspergillus niger 8.95±0.06 12.56±0.40 
Alternaria alternata 9.57±0.47 15.11±0.12 
Colletotrichum gloeosporioides 21.13±0.12 12.5±0.5 
Control 42.8±0.42 38.56±0.2 
Values are means of three replicates±Standard Deviation 
 
A list of endophytic fungi isolated from a number of medicinal plants 
have been claimed to possess antifungal activities by some 
researchers [19-21]. Most of them were anamorphs of fungi 
distributed in some common endophytic genera such as 
Colletotrichum sp., Alternaria sp., Ovulariopsis sp., Pestalotiopsis sp., 
Phomopsis sp., and Phoma sp., of which most are known to produce 
various bioactive products [22, 23]. The findings of this study 
coincide with the report of Kaushal Kanwer Shekhawat [24], which 
states that the Aspergillus flavus an endophytic fungus of Melia 
azedarach displayed greater fungicidal activity against Penicillium 
chrysogenum and Fusarium oxysporum with a inhibition zone of 
17.05±0.2 than Trichoderma koningii with a inhibition zone of 
12.08±0.9). Yet in another study the antifungal metabolites,named 
Asperfumoid, Physcion, Fumigaclavine, Fumitremorgin and Helvolic 
acid were obtained from an endophytic fungus, Aspergillus 
fumigatus, isolated from the leaf of Cynodon dactylon inhibited the 
growth of Candida albicans [25]. Aspergillus clavatonanicus, an 
endophytic fungal strain from Taxus mairei yielded Clavatol and 
Patulin which also possesses inhibitory activity against several plant 
pathogenic fungi, namely Botrytis cinerea, Didymella bryoniae, 
Fusarium oxysporum, Rhizoctonia solani and Pythium ultimum [26]. 
An endophytic fungus, Aspergillus niger isolated from marine brown 
alga Colpomenia sinuosa released the compound Asperamide A and B 
sphingolipid and their corresponding glycosphingolipid possessing a 
hitherto unreported 9-methyl-C20-sphingosine moiety displayed 
moderate activity against Candida albicans with a zone of inhibition 
of 20 mm [27]. Isofusidienol were produced by Chalara sp. an 
endophytic fungus isolated from Artemisia vulgaris exhibited 
antifungal activity against Candida albicans [28].  
Colletotric acid, a metabolite of Colletotrichum gloeosporioides, an 
endophytic fungus from the plant Artemisia mongolica, displayed 
antimicrobial activity against bacteria as well as against fungus, 
Helminthosporium sativum [29]. In another study Colletotrichum sp. 
isolated from Artemisia annua, produces bioactive metabolites that 
showed varied antibacterial and antifungal activity [30]. Similar to our 
study, (KA) kojic acid, a natural pyrone, is reported as a potent chemo 
sensitizing agent of complex III inhibitors disrupting the mitochondrial 
respiratory chain in fungi thereby acting as an antifungal agent [31]. 
In the present study Lanosterol 14-alpha demethylase (PDB ID: 
3LD6) has been chosen as a target protein, which has been isolated 
from Homo sapiens with a resolution of 2.80A and has 461 amino 
acids. The compounds (table 2) identified by GC-MS analysis was 
screened against the target protein. 
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Table 2: Chemical constituents present in ethyl acetate extract of Aspergillus flavus 
S. No. Chemical constituents ID 
1 Kojic Acid 3840 
2 Octadecanoic acid 5213 
3 n-Hexadecanoic Acid 985 
4 Diethyl Phthlate 6781 
5 3-Phenyl Propionic Acid 107 
6 Fluconazole (std) 3365 
 
Molecular docking was done at site 3, which was chosen as the 
active site with a volume 38.125Ǻ  with point count of 305 in equal 
grid spacing of 0.5 (X), 0.5(Y), 0.5(Z) direction respectively. The 
chemical constituents identified from the ethyl acetate extract of 
endophytic Aspergillus flavus were docked with a sphere site being 
defined as 18.348 (X),-9.95 (Y), 5.039 (Z) using "2 500 120, 4 1200 
300, 6 1500 350, 10 2000 500, 25 3000 750" Number of Monte 
Carlo Trials. 
 
Table 3: Docking analysis of identified compounds with target protein 3LD6 
S. 
No. 
Compounds Dock score in 
Kcal/mol 
Internal energy in 
Kcal 
Interacting amino acid  
residues 
1 Kojic Acid 22.933 -0.544 ASN430,PRO431,ARG425,ASP429,VAL416,GLN428 
2 Octadecanoic acid 37.045 -3.862 TRP415,ARG425,PRO431,VAL416,GLN428,ASP420,ASN422,GLU417 
3 n hexadecanioc acid 39.491 -6.698 ASN422,VAL416,ASN430,ARG425,GLU417,GLN428 
4 Diethyl phylate 31.548 -2.665 ASP420GLU417,VAL416,ASN422,TRP415,SER414,ARG425,PRO 
431 
5 3-Phenyl propionic 
acid 
29.286 -0.76 ASP420,GLU417,VAL416,ASN422,TRP415,SER414, 
ARG425,PRO431 
6 Flucanozole 17.152 -4.484 ASN429,VAL416,GLN428 
 
Table 3 and fig. 1 represents the results of the docked compounds 
after docking. The result shows the highest dock score of 39.491 
Kcal/mol with an internal energy of-6.698 Kcal for n-hexadecanioc 
acid at the binding site of the target protein which is better than the 
standard inhibitor Flucanozole, with a dock score of 17.152 
Kcal/mol and with an internal energy of-4.484 Kcal (fig. 2). In this 
study n-hexadecanioc acid has been found to be more stable than the 
standard with an internal energy of-6.698 K cal. Moreover, all the 
compounds were able to bind at active site of the target protein, and 
the interacting amino acid is depicted in (table 3) thereby indicating 









Fig. 1: Illustration of compounds docked with target protein 3LD6 (A) Kojic acid (B) Octadecanoic acid (C) n-Hexadecanoic acid (D) 
Diethyl phylate (E) 3-Phenyl propionic acid (F) Flucanozole fig. 2: Dock Score and internal energy of compounds with target protein 3LD6 
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The Flucanozole inhibits fungal CYP51, lanosterol demethylase by 
binding reversibly to the heme cofactor located in the enzyme active 
site in a competitive manner [32]. As a result methylated sterol 
precursors of ergosterol gets accumulated which causes membrane 
disruption thereby preventing fungal growth [33]. In our studies, on 
the basis of analysis of interacting amino acid (table 3) it has been 
found out that these ligands also interacts with the target protein 
similar to that of Flucanozole, Hence it may be predicted that these 
ligands may also bind to the heme cofactor, thereby rendering the 
enzyme inactive. 
CONCLUSION 
The compounds isolated from an endophyte, Aspergillus flavus in 
this study namely Kojic acid, Octadecanoic acid, n-Hexadecanoic 
acid, Diethyl phylate and 3-Phenyl propionic acid, are known 
compounds for their antimicrobial activity. Hence, the synergetic 
action of these compounds might be the possible reason for its 
activity against the fungal pathogens like Candida albicans and 
Malassezia pachydermis. Moreover, this is the first report that Kojic 
acid has been isolated from the endophytic fungi grown in a very 
common Indian tree Lannea coromandelica. Observations in this 
research have important implications for the production of kojic acid 
at a low cost which may turn to be of wide significance in health, 
pharmaceutical, food and cosmetic industries. Increase in the yields 
of these products may also be enhanced by studying the biochemical 
pathways, new developments in fermentation technology, 
membrane technologies and genetic manipulation. 
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